Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23 studies found for:    Open Studies | "Graves Disease"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Graves Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
2 Recruiting ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy
Condition: Graves Disease
Intervention: Biological: ATX-GD-59
3 Recruiting A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: CFZ533
4 Recruiting K1-70 - A Study in Subjects With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: K1-70 intramuscular
5 Recruiting D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
Condition: Graves' Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
6 Recruiting Thyroid Disease and Personality Study
Condition: Graves' Disease
Intervention: Procedure: blood sampling
7 Recruiting Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Condition: Graves' Hyperthyroidism
Interventions: Dietary Supplement: Selenium;   Other: Placebo
8 Recruiting Post-Radioiodine Graves' Management: The PRAGMA-Study
Condition: Graves' Disease
Intervention:
9 Not yet recruiting Role of the Microbiome in Graves' Orbitopathy
Condition: Graves' Disease
Intervention: Biological: LAB4
10 Recruiting Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans
Conditions: Hyperthyroidism;   Tomography;   Emission-Computed;   Single-Photon
Intervention:
11 Recruiting The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
Conditions: Hypothyroidism;   Exophthalmos
Intervention: Radiation: Iodine 131
12 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
13 Recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Intervention:
14 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
15 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
16 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
17 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
18 Recruiting Celecoxib for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Celecoxib;   Drug: artificial tears
19 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo
20 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease
Interventions: Drug: ASTED;   Dietary Supplement: Selenium;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.